バイオ医薬品添加剤市場レポート：2030年までの動向、予測、競合分析

バイオ医薬品添加剤の動向と予測

世界のバイオ医薬品添加剤市場は、2024年から2030年までのCAGRが5.6%で、2030年までに推定40億米ドルに達すると予想されます。この市場の主な促進要因は、多機能添加剤の採用が増加していることと、製薬企業がジェネリック市場に注力するようになっていることです。世界のバイオ医薬品添加剤市場の将来は、可溶化・界面活性剤／乳化剤、ポリオール、炭水化物市場に機会があり、有望視されています。

バイオ医薬品添加剤市場の洞察

Lucintelは、タンパク質治療薬の需要増加により、炭水化物が予測期間中最大のセグメントであり続けると予測しています。

北米はバイオ医薬品製造のニーズが高いため、予測期間中も最大地域であり続けるでしょう。

よくある質問

Q1.市場規模は？

A1.世界のバイオ医薬品添加剤市場は、2030年までに推定40億米ドルに達すると予想されています。

Q2.市場の成長予測は？

A2.世界のバイオ医薬品添加剤市場は、2024年から2030年にかけてCAGR 5.6%で成長すると予想されています。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は、多機能添加剤の採用が増加していることと、製薬企業がジェネリック市場に注力するようになっていることです。

Q4.市場の主要セグメントは？

A4.バイオ医薬品添加剤市場の将来は、可溶化・界面活性剤/乳化剤、ポリオール、炭水化物市場に機会があり、有望です。

Q5.市場の主要企業は？

A5.バイオ医薬品添加剤の主要企業は以下の通りです。

• Merck
• Colorcon
• BASF
• Associated British Foods
• Signet Excipients
• Sigachi Industries
• Spectrum Chemical Manufacturing
• Roquette Freres
• IMCD
• Clariant

Q6.今後、最大となる市場セグメントは？

A6.Lucintelは、タンパク質治療薬の需要増加により、炭水化物が予測期間中最大のセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.北米はバイオ医薬品製造のニーズが高いため、予測期間中も最大地域であり続ける。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界のバイオ医薬品添加剤市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のバイオ医薬品添加剤市場動向（2018-2023）および予測（2024-2030）
• 製品別の世界のバイオ医薬品添加剤市場
  • 可溶化剤および界面活性剤/乳化剤
  • ポリオール
  • 炭水化物

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界のバイオ医薬品添加剤市場
• 北米のバイオ医薬品添加剤市場
• 欧州のバイオ医薬品添加剤市場
• アジア太平洋のバイオ医薬品添加剤市場
• その他地域のバイオ医薬品添加剤市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 製品別の世界のバイオ医薬品添加剤市場の成長機会
  • 地域別の世界のバイオ医薬品添加剤市場の成長機会
• 世界のバイオ医薬品添加剤市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のバイオ医薬品添加剤市場の能力拡大
  • 世界のバイオ医薬品添加剤市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Merck
• Colorcon
• BASF
• Associated British Foods
• Signet Excipients
• Sigachi Industries
• Spectrum Chemical Manufacturing
• Roquette Freres
• IMCD
• Clariant

Biopharmaceuticals Exicipents Trends and Forecast

The future of the global biopharmaceuticals exicipents market looks promising with opportunities in the solubilizes & surfactants/emulsifiers, polyols, and carbohydrates markets. The global biopharmaceuticals exicipents market is expected to reach an estimated $4 billion by 2030 with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are increasing adoption of multifunctional excipients and growing focus of pharmaceutical players on the generic market.

A more than 150-page report is developed to help in your business decisions.

Biopharmaceuticals Exicipents by Segment

The study includes a forecast for the global biopharmaceuticals exicipents by products and region.

Biopharmaceuticals Exicipents Market by Products [Shipment Analysis by Value from 2018 to 2030]:

• Solubilizes & Surfactants/Emulsifiers
• Polyols
• Carbohydrates

Biopharmaceuticals Exicipents Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Biopharmaceuticals Exicipents Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biopharmaceuticals exicipents companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biopharmaceuticals exicipents companies profiled in this report include-

• Merck
• Colorcon
• BASF
• Associated British Foods
• Signet Excipients
• Sigachi Industries
• Spectrum Chemical Manufacturing
• Roquette Freres
• IMCD
• Clariant

Biopharmaceuticals Exicipents Market Insights

Lucintel forecasts that carbohydrates will remain the largest segment over the forecast period due to increasing demand for protein therapeutics.

North America will remain the largest region over the forecast period due to substantial need for biopharmaceutical production.

Features of the Global Biopharmaceuticals Exicipents Market

Market Size Estimates: Biopharmaceuticals exicipents market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biopharmaceuticals exicipents market size by products, region, and region in terms of value ($B).

Regional Analysis: Biopharmaceuticals exicipents market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products and regions for the biopharmaceuticals exicipents market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biopharmaceuticals exicipents market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the biopharmaceuticals exicipents market size?

Answer: The global biopharmaceuticals exicipents market is expected to reach an estimated $4 billion by 2030.

Q2. What is the growth forecast for biopharmaceuticals exicipents market?

Answer: The global biopharmaceuticals exicipents market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the biopharmaceuticals exicipents market?

Answer: The major drivers for this market are increasing adoption of multifunctional excipients and growing focus of pharmaceutical players on the generic market.

Q4. What are the major segments for biopharmaceuticals exicipents market?

Answer: The future of the biopharmaceuticals exicipents market looks promising with opportunities in the solubilizes & surfactants/emulsifiers, polyols, and carbohydrates markets.

Q5. Who are the key biopharmaceuticals exicipents market companies?

Answer: Some of the key biopharmaceuticals exicipents companies are as follows.

• Merck
• Colorcon
• BASF
• Associated British Foods
• Signet Excipients
• Sigachi Industries
• Spectrum Chemical Manufacturing
• Roquette Freres
• IMCD
• Clariant

Q6. Which biopharmaceuticals exicipents market segment will be the largest in future?

Answer: Lucintel forecasts that carbohydrates will remain the largest segment over the forecast period due to increasing demand for protein therapeutics.

Q7. In biopharmaceuticals exicipents market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to substantial need for biopharmaceutical production.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the biopharmaceuticals exicipents market by products (solubilizes & surfactants/emulsifiers, polyols, and carbohydrates) and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biopharmaceuticals Exicipents Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Biopharmaceuticals Exicipents Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Biopharmaceuticals Exicipents Market by Products
  • 3.3.1: Solubilizes & Surfactants/Emulsifiers
  • 3.3.2: Polyols
  • 3.3.3: Carbohydrates

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Biopharmaceuticals Exicipents Market by Region
• 4.2: North American Biopharmaceuticals Exicipents Market
• 4.3: European Biopharmaceuticals Exicipents Market
  • 4.3.1: European Biopharmaceuticals Exicipents Market by Products: Solubilizes & Surfactants/Emulsifiers, Polyols, and Carbohydrates
• 4.4: APAC Biopharmaceuticals Exicipents Market
  • 4.4.1: APAC Biopharmaceuticals Exicipents Market by Products: Solubilizes & Surfactants/Emulsifiers, Polyols, and Carbohydrates
• 4.5: ROW Biopharmaceuticals Exicipents Market
  • 4.5.1: ROW Biopharmaceuticals Exicipents Market by Products: Solubilizes & Surfactants/Emulsifiers, Polyols, and Carbohydrates

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Biopharmaceuticals Exicipents Market by Products
  • 6.1.2: Growth Opportunities for the Global Biopharmaceuticals Exicipents Market by Region
• 6.2: Emerging Trends in the Global Biopharmaceuticals Exicipents Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Biopharmaceuticals Exicipents Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biopharmaceuticals Exicipents Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Merck
• 7.2: Colorcon
• 7.3: BASF
• 7.4: Associated British Foods
• 7.5: Signet Excipients
• 7.6: Sigachi Industries
• 7.7: Spectrum Chemical Manufacturing
• 7.8: Roquette Freres
• 7.9: IMCD
• 7.10: Clariant